Markets:

Overview

News

Currencies

International

Treasuries

Innocan Pharma Corp (CSE:INNO)

15.70 -0.80 (-4.85%)

Streaming Delayed Price Updated: 2:22 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Innocan Pharma Corp

< Previous 1 2 Next >

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark ↗

May 28, 2024

Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.

Via Benzinga

This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain ↗

April 23, 2024

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration...

Via Benzinga

534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations ↗

April 02, 2024

Innocan Pharma's 2023 earnings report: Revenue soars 534%, operating loss down 61%, $1.5M capital raise. CEO shares strategic vision.

Via Benzinga

CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval ↗

February 13, 2024

Cannabinoid-focused pharmaceutical company Innocan Pharma Corp expects preliminary revenues of $4.89m in Q4 of fiscal 2023, representing a YoY increase of 331%. It said preliminary revenues are...

Via Benzinga

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 ↗

December 22, 2023

This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and...

Via Benzinga

Topics Cannabis

More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It ↗

October 23, 2023

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has closed the second and final tranche of its previously announced private placement offering of its units.

Via Benzinga

Topics Cannabis

CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare ↗

September 21, 2023

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has entered into an agreement with Research Capital Corporation as the sole agent and sole book-runner on a "best efforts" agency basis...

Via Benzinga

Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales ↗

August 28, 2023

Innocan Pharma Corporation (CSE: INNO)(FSE: IP4) (OTC: INNPF), a pharmaceutical technology firm specializing in innovative drug delivery platforms,

Via Benzinga

Industry Update: Innocan Pharma Accelerates Commercialization in Europe Following Impressive Revenue Growth

May 03, 2023

Via AB Newswire

Topics Intellectual Property

Innovative Delivery Systems Create Unique Opportunities in the Billion-Dollar Pain Market (CSE: INNO)

November 14, 2022

Via AB Newswire

Topics Cannabis

Innocan Pharma Provides an Operational Update

September 21, 2022

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 21, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...

Via Newsfile

Topics Intellectual Property

Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment

September 09, 2022

A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant)...

Via Newsfile

Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

September 06, 2022

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals

September 03, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021

August 27, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 27, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University

August 18, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada

August 11, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)

August 03, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss

July 28, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...

Via Newsfile

Topics Intellectual Property Supply Chain

Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee

July 14, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Artificial Intelligence Supply Chain

Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms

July 09, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland

July 01, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 1, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Economy Supply Chain

Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study

June 24, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution

June 16, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 16, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment

June 14, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study

June 11, 2021

Herzliya, Israel and Calgary Alberta--(Newsfile Corp. - June 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference

June 09, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study

May 14, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program

May 10, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...

Via Newsfile

Topics Cannabis Supply Chain

Innocan Pharma Announces Trading on the OTCQB Venture Market and DTC Eligibility of Its Common Shares in the United States

May 06, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Innocan Pharma Corp (CSE:INNO)

All News about Innocan Pharma Corp

Starting at $3.75/week.

Subscribe Today